STOCK TITAN

KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

KORU Medical Systems (NASDAQ: KRMD) will report its third quarter 2022 financial results on November 9, 2022, at 4:30 p.m. ET. Management will host a conference call to discuss results and updates. The company is known for its innovative home infusion solutions, including the FREEDOM Syringe Infusion System. Interested parties can access the call at (877)-407-0784 for U.S. callers or (201)-689-8560 for international participants, using conference ID 13732861. Full details available on their website.

Positive
  • Upcoming third quarter financial results expected to provide insights into business performance.
  • KORU Medical specializes in innovative home infusion solutions, indicating potential market growth.
  • Management engagement through conference call suggests transparency and investor relations focus.
Negative
  • None.

MAHWAH, N.J.--(BUSINESS WIRE)-- KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report third quarter 2022 financial results on Wednesday, November 9, 2022. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.

Conference Call and Webcast Details

The conference call can be accessed by dialing (877)-407-0784 for participants in the U.S. or Canada and (201)-689-8560 for international callers, using conference ID: 13732861. A live and archived webcast of the event can be accessed via the IR Calendar on the News/Events page of the Investors section of KORU Medical’s website at www.korumedical.com. The archived webcast will be available for six months.

About KORU Medical Systems

KORU Medical Systems develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing and HIgH-Flo Subcutaneous Safety Needle Sets. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.

Investor Contact:

Greg Chodaczek

347-620-7010

investor@korumedical.com

Source: KORU Medical Systems

FAQ

When will KORU Medical report its third quarter 2022 financial results?

KORU Medical will report its third quarter 2022 financial results on November 9, 2022.

What time is KORU Medical's conference call on financial results?

The conference call will take place at 4:30 p.m. ET on November 9, 2022.

How can I access KORU Medical's conference call?

You can access the call by dialing (877)-407-0784 for U.S. participants or (201)-689-8560 for international callers, using conference ID 13732861.

What products does KORU Medical specialize in?

KORU Medical specializes in innovative home infusion solutions, including the FREEDOM Syringe Infusion System.

KORU Medical Systems, Inc.

NASDAQ:KRMD

KRMD Rankings

KRMD Latest News

KRMD Stock Data

115.56M
45.86M
6.3%
54.37%
1.1%
Medical Instruments & Supplies
Surgical & Medical Instruments & Apparatus
Link
United States of America
MAHWAH